[Federal Register: March 15, 2004 (Volume 69, Number 50)]
[Notices]               
[Page 12157-12158]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr15mr04-66]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Program Announcement 04074]

 
Achieve and Sustain Measles, Rubella, and Congenital Rubella 
Syndrome (CRS) Elimination in the Americas Notice of Intent To Fund 
Single Eligibility Award

A. Purpose

    The Centers for Disease Control and Prevention (CDC) announces the 
intent to fund fiscal year (FY) 2004 funds for a cooperative agreement 
program to achieve and sustain measles, rubella, and congenital rubella 
syndrome (CRS) elimination in the Americas. The Catalog of Federal 
Domestic Assistance number for this program is 93.185.

B. Eligible Applicant

    Assistance will be provided only to Pan American Health 
Organization (PAHO). PAHO is the most appropriate and qualified agency 
to conduct the activities under this cooperative agreement because:
    1. PAHO has the lead responsibility among the United Nations 
organizations for implementing activities to achieve the Pan American 
Sanitary Conference resolution of 1994 calling for the regional 
elimination of measles, and the year 2003 resolution calling for the 
elimination of rubella and CRS by year 2010. PAHO is the only 
organization in the Americas with a regional mandate for the control 
and prevention of vaccine-preventable diseases (VPD).
    2. The proposed program is strongly supportive of, and directly 
related to, the achievement of PAHO and CDC/National Immunization 
Program objectives for the control and prevention of VPDs with emphasis 
on CDC's objectives.
    3. PAHO, in collaboration with the Governments of Brazil, Canada, 
Netherlands, Spain, USAID, March of Dimes, Sabin Institute, American 
Red Cross and CDC, are partners in an international effort to increase 
support and visibility for both the measles and rubella elimination 
initiatives.

C. Funding

    Approximately $6,000,000 is available in FY 2004 to fund this 
award. It is expected that the award will begin on or before May 1, 
2004, and will be made for a 12-month budget period within a project 
period of up to five years. Funding estimates may change.

[[Page 12158]]

D. Where To Obtain Additional Information

    For general comments or questions about this announcement, contact: 
Technical Information Management, CDC Procurement and Grants Office, 
2920 Brandywine Road, Atlanta, GA 30341-4146, Telephone: 770-488-2700.
    For technical questions about this program, contact: Leo F. 
Weakland, Project Officer, Global Immunization Division, National 
Immunization Program,Centers for Disease Control and Prevention, 
Mailstop E-05, Atlanta, Georgia 30333, telephone: 404-639-8252, E-mail 
Address: lfwo@cdc.gov.

    Dated: March 9, 2004.
Sandra R. Manning,
Director, Procurement and Grants Office, Centers for Disease Control 
and Prevention.
[FR Doc. 04-5740 Filed 3-12-04; 8:45 am]

BILLING CODE 4163-18-P